{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:18:18Z","timestamp":1782929898071,"version":"3.54.5"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SR\/FST\/LS-1\/2023\/1176"],"award-info":[{"award-number":["SR\/FST\/LS-1\/2023\/1176"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["BIM\/11(20)\/2022"],"award-info":[{"award-number":["BIM\/11(20)\/2022"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.compbiomed.2025.110001","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T03:33:22Z","timestamp":1741664002000},"page":"110001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The coevolutionary landscape of drug resistance in epidermal growth factor receptor: A cancer perspective"],"prefix":"10.1016","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4165-293X","authenticated-orcid":false,"given":"Gyan Prakash","family":"Rai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6456-1363","authenticated-orcid":false,"given":"Asheesh","family":"Shanker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2025.110001_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canlet.2019.10.030","article-title":"EGFR-mediated autophagy in tumourigenesis and therapeutic resistance","volume":"469","author":"Wu","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.compbiomed.2025.110001_bib2","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73218","article-title":"A molecular mechanism for the generation of Ligand-dependent differential outputs by the epidermal growth factor receptor","volume":"10","author":"Huang","year":"2021","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110001_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cells6020013","article-title":"Activation of the EGF receptor by ligand binding and oncogenic mutations: the \u201crotation model.\u201d","volume":"6","author":"Purba","year":"2017","journal-title":"Cells"},{"issue":"23","key":"10.1016\/j.compbiomed.2025.110001_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312865","article-title":"Protein tyrosine phosphatases: mechanisms in cancer","volume":"22","author":"Sivaganesh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.compbiomed.2025.110001_bib5","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.3390\/healthcare11222920","article-title":"Epidemiological analysis of global and regional lung cancer mortality: based on 30-year data analysis of global burden disease database","volume":"11","author":"Ji","year":"2023","journal-title":"Healthcare"},{"issue":"10299","key":"10.1016\/j.compbiomed.2025.110001_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110001_bib7","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.21037\/jtd-23-401","article-title":"Dysregulated expression of microRNA involved in resistance to osimertinib in EGFR mutant non-small cell lung cancer cells","volume":"15","author":"Zhang","year":"2023","journal-title":"J. Thorac. Dis."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110001_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030841","article-title":"Osimertinib resistance: molecular mechanisms and emerging treatment options","volume":"15","author":"Gomatou","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.compbiomed.2025.110001_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.lungcan.2019.08.002","article-title":"A meta-analysis of adjuvant EGFR-TKIs for patients with resected non-small cell lung cancer","volume":"137","author":"Cheng","year":"2019","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110001_bib10","first-page":"1","article-title":"Personalized prediction of EGFR mutation-induced drug resistance in lung cancer","volume":"3","author":"Wang","year":"2013","journal-title":"Scientific Reports 2013"},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110001_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081887","article-title":"Role of EGFR in the nervous system","volume":"9","author":"Romano","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.compbiomed.2025.110001_bib12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.semcancer.2019.09.015","article-title":"Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer","volume":"61","author":"Harrison","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110001_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.compbiomed.2025.110001_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152708","article-title":"Gastrointestinal stromal tumors - summary of mutational status of the primary\/secondary KIT\/PDGFRA mutations, BRAF mutations and SDH defects","volume":"215","author":"Kalfusova","year":"2019","journal-title":"Pathol. Res. Pract."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110001_bib15","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.21037\/jtd.2019.08.32","article-title":"Advances in targeting acquired resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors","volume":"12","author":"Chen","year":"2020","journal-title":"J. Thorac. Dis."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110001_bib16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41573-021-00195-4","article-title":"Kinase drug discovery 20 years after imatinib: progress and future directions","volume":"20","author":"Cohen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110001_bib17","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0709662105","article-title":"The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP","volume":"105","author":"Yun","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.compbiomed.2025.110001_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107204","article-title":"Gefitinib derivatives and drug-resistance: a perspective from molecular dynamics simulations","volume":"163","author":"Ahmadi","year":"2023","journal-title":"Comput. Biol. Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110001_bib19","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.cllc.2017.06.004","article-title":"Clinical implications of the T790M mutation in disease characteristics and treatment response in patients with epidermal growth factor receptor (EGFR)-Mutated non-small cell lung cancer (NSCLC)","volume":"19","author":"Gaut","year":"2018","journal-title":"Clin. Lung. Cancer"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110001_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-019-0818-2","article-title":"Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy","volume":"12","author":"Lim","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.compbiomed.2025.110001_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-019-0573-8","article-title":"Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer","volume":"121","author":"Leonetti","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.compbiomed.2025.110001_bib22","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34300","article-title":"Coevolution-based inference of amino acid interactions underlying protein function","volume":"7","author":"Salinas","year":"2018","journal-title":"Elife"},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110001_bib23","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1258\/ebm.2011.010264","article-title":"Structural basis and sequence co-evolution analysis of the hemagglutinin protein of pandemic influenza A\/H1N1 (2009) virus","volume":"236","author":"Tse","year":"2011","journal-title":"Exp. Biol. Med."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110001_bib24","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1080\/07391102.2013.793211","article-title":"Understanding the evolutionary relationship of hemagglutinin protein from influenza viruses using phylogenetic and molecular modeling studies","volume":"32","author":"Karthikeyan","year":"2014","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110001_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001301","article-title":"Prevalence of epistasis in the evolution of influenza A surface proteins","volume":"7","author":"Kryazhimskiy","year":"2011","journal-title":"PLoS Genet."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110001_bib26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.gene.2011.09.024","article-title":"Comparative analysis of hemagglutinin of 2009 H1N1 influenza A pandemic indicates its evolution to 1918 H1N1 pandemic","volume":"491","author":"Masoodi","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.compbiomed.2025.110001_bib27","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.csbj.2019.10.005","article-title":"Coevolutive, evolutive and stochastic information in protein-protein interactions","volume":"17","author":"Andrade","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110001_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijantimicag.2018.10.027","article-title":"Groups of coevolving positions provide drug resistance to Mycobacterium tuberculosis: a study using targets of first-line antituberculosis drugs","volume":"53","author":"Vats","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.compbiomed.2025.110001_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104646","article-title":"Coevolutionary forces shaping the fitness of SARS-CoV-2 spike glycoprotein against human receptor ACE2","volume":"87","author":"Priya","year":"2021","journal-title":"Infect. Genet. Evol."},{"issue":"12","key":"10.1016\/j.compbiomed.2025.110001_bib30","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1002\/pro.3318","article-title":"Protein\u2013protein interactions leave evolutionary footprints: high molecular coevolution at the core of interfaces","volume":"26","author":"Teppa","year":"2017","journal-title":"Protein Sci."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110001_bib31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrg3414","article-title":"Emerging methods in protein co-evolution","volume":"14","author":"De Juan","year":"2013","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110001_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2023.119592","article-title":"Coevolution-based computational approach to detect resistance mechanism of epidermal growth factor receptor","volume":"1871","author":"Rai","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"17","key":"10.1016\/j.compbiomed.2025.110001_bib33","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","article-title":"Gapped BLAST and PSI-BLAST: a new generation of protein database search programs","volume":"25","author":"Altschul","year":"1997","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110001_bib34","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/molbev\/mst010","article-title":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability","volume":"30","author":"Katoh","year":"2013","journal-title":"Mol. Biol. Evol."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110001_bib35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/sysbio\/syq010","article-title":"New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0","volume":"59","author":"Guindon","year":"2010","journal-title":"Syst. Biol."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110001_bib36","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/molbev\/msn067","article-title":"An improved general amino acid replacement matrix","volume":"25","author":"Le","year":"2008","journal-title":"Mol. Biol. Evol."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110001_bib37","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/molbev\/msi183","article-title":"A model-based approach for detecting coevolving positions in a molecule","volume":"22","author":"Dutheil","year":"2005","journal-title":"Mol. Biol. Evol."},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110001_bib38","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110001_bib39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1021\/acs.biochem.6b00572","article-title":"Computational and experimental characterization of patient derived mutations reveal an unusual mode of regulatory spine assembly and drug sensitivity in EGFR kinase","volume":"56","author":"Ruan","year":"2017","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110001_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13050747","article-title":"Untangling dual-targeting therapeutic mechanism of epidermal growth factor receptor (Egfr) based on reversed allosteric communication","volume":"13","author":"Qiu","year":"2021","journal-title":"Pharmaceutics"},{"issue":"W1","key":"10.1016\/j.compbiomed.2025.110001_bib41","doi-asserted-by":"crossref","first-page":"W350","DOI":"10.1093\/nar\/gky300","article-title":"DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability","volume":"46","author":"Rodrigues","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.110001_bib42","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","author":"Trott","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110001_bib43","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/bioinformatics\/bty816","article-title":"Large-scale prediction of binding affinity in protein\u2013small ligand complexes: the PRODIGY-LIG web server","volume":"35","author":"Vangone","year":"2019","journal-title":"Bioinformatics"},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110001_bib44","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1021\/acs.jctc.7b00500","article-title":"Povme 3.0: software for mapping binding pocket flexibility","volume":"13","author":"Wagner","year":"2017","journal-title":"J. Chem. Theor. Comput."},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110001_bib45","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcc.21816","article-title":"SwissParam: a fast force field generation tool for small organic molecules","volume":"32","author":"Zoete","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2025.110001_bib46","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jmgm.2021.108021","article-title":"Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): a computational drug discovery study","volume":"109","author":"Reyaz","year":"2021","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.compbiomed.2025.110001_bib47","doi-asserted-by":"crossref","unstructured":"Abraham, M. J., Murtola, T., Schulz, R., P\u00e1ll, S., Smith, J. C., Hess, B., & Lindahl, E. (n.d.). ScienceDirect GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001.","DOI":"10.1016\/j.softx.2015.06.001"},{"issue":"21","key":"10.1016\/j.compbiomed.2025.110001_bib48","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1021\/acs.jcim.3c01053","article-title":"SwissParam 2023: a modern web-based tool for efficient small molecule parametrization","volume":"63","author":"Bugnon","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110001_bib49","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/jcc.21726","article-title":"Combination of the CHARMM27 force field with united-atom lipid force fields","volume":"32","author":"Sapay","year":"2011","journal-title":"J. Comput. Chem."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110001_bib50","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM General Force Field (CGenFF): a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110001_bib51","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/wics.117","article-title":"Steepest descent","volume":"2","author":"Meza","year":"2010","journal-title":"Wiley Interdisciplinary Reviews: Comput. Stat."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110001_bib52","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"issue":"12","key":"10.1016\/j.compbiomed.2025.110001_bib53","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110001_bib54","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"G-mmpbsa -A GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110001_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116073","article-title":"Allosteric binding sites of a\u03b2 peptides on the acetylcholine synthesizing enzyme ChAT as deduced by in silico molecular modeling","volume":"23","author":"Baidya","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110001_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183253","article-title":"Principal component analysis highlights the influence of temperature, curvature and cholesterol on conformational dynamics of lipids","volume":"1862","author":"Buslaev","year":"2020","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110001_bib57","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0006-3495(03)74687-6","article-title":"Protein dynamics, thermal stability, and free-energy landscapes: a molecular dynamics investigation","volume":"85","author":"Tavernelli","year":"2003","journal-title":"Biophys. J."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110001_bib58","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s10930-020-09953-6","article-title":"Structure-based identification of potential drugs against FmtA of Staphylococcus aureus: virtual screening, molecular dynamics, MM-GBSA, and QM\/MM","volume":"40","author":"Dalal","year":"2021","journal-title":"Protein J."},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110001_bib59","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jmgm.2009.01.006","article-title":"Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case","volume":"27","author":"Papaleo","year":"2009","journal-title":"J. Mol. Graph. Model."},{"issue":"19","key":"10.1016\/j.compbiomed.2025.110001_bib60","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.95.19.11158","article-title":"Clustering of low-energy conformations near the native structures of small proteins","volume":"95","author":"Shortle","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.compbiomed.2025.110001_bib61","doi-asserted-by":"crossref","unstructured":"Brown, D. K., Penkler, D. L., Amamuddy, O. S., Ross, C., Atilgan, A. R., Atilgan, C., Ozlem, \u20ac, & Bishop, T. (n.d.). MD-TASK: a software suite for analyzing molecular dynamics trajectories. https:\/\/doi.org\/10.1093\/bioinformatics\/btx349.","DOI":"10.1093\/bioinformatics\/btx349"},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110001_bib62","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/1062936X.2023.2261842","article-title":"Assessing structural insights into in-house arylsulfonyl L-(+) glutamine MMP-2 inhibitors as promising anticancer agents through structure-based computational modelling approaches","volume":"34","author":"Baidya","year":"2023","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.compbiomed.2025.110001_bib63","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/prot.24734","article-title":"Characterization of the differences in the cyclopiazonic acid binding mode to mammalian and P. Falciparum Ca 21 pumps: a computational study","volume":"83","author":"Marino","year":"2015","journal-title":"Proteins STRUCTURE O FUNCTION O BIOINFORMATICS Proteins"},{"key":"10.1016\/j.compbiomed.2025.110001_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2020.107322","article-title":"Geo-Measures: a PyMOL plugin for protein structure ensembles analysis","volume":"87","author":"Kagami","year":"2020","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.compbiomed.2025.110001_bib65","article-title":"Structure-based computer-aided drug design to identify potential lead molecules for Asparaginyl Endopeptidase inhibitors","author":"Singh","year":"2024","journal-title":"J. Biomol. Struct. Dynam."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110001_bib66","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theor. Comput."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110001_bib67","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"Gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"issue":"suppl_1","key":"10.1016\/j.compbiomed.2025.110001_bib68","doi-asserted-by":"crossref","first-page":"i126","DOI":"10.1093\/bioinformatics\/bti1032","article-title":"Detecting coevolving amino acid sites using Bayesian mutational mapping","volume":"21","author":"Dimmic","year":"2005","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110001_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2148-11-266","article-title":"Coevolution of amino acid residues in the key photosynthetic enzyme Rubisco","volume":"11","author":"Wang","year":"2011","journal-title":"BMC Evol. Biol."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110001_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/v12030254","article-title":"Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies","volume":"12","author":"Ahmed","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.compbiomed.2025.110001_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107233","article-title":"Coevolution based immunoinformatics approach considering variability of epitopes to combat different strains: a case study using spike protein of SARS-CoV-2","volume":"163","author":"Mishra","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.compbiomed.2025.110001_bib72","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.imlet.2018.10.008","article-title":"Generation of cancer vaccine immunogens derived from major histocompatibility complex (MHC) class I molecules using variable epitope libraries","volume":"204","author":"Serv\u00edn-Blanco","year":"2018","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.compbiomed.2025.110001_bib73","article-title":"Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"issue":"34","key":"10.1016\/j.compbiomed.2025.110001_bib74","doi-asserted-by":"crossref","first-page":"9122","DOI":"10.1073\/pnas.1702664114","article-title":"Origins of coevolution between residues distant in protein 3D structures","volume":"114","author":"Anishchenko","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"20","key":"10.1016\/j.compbiomed.2025.110001_bib75","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1038\/emboj.2008.189","article-title":"Protein co-evolution, co-adaptation and interactions","volume":"27","author":"Pazos","year":"2008","journal-title":"EMBO J."},{"issue":"W1","key":"10.1016\/j.compbiomed.2025.110001_bib76","doi-asserted-by":"crossref","first-page":"W395","DOI":"10.1093\/nar\/gkv343","article-title":"ENCoM server: exploring protein conformational space and the effect of mutations on protein function and stability","volume":"43","author":"Frappier","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.110001_bib77","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/nar\/gkx439","article-title":"SDM: a server for predicting effects of mutations on protein stability","volume":"45","author":"Pandurangan","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.110001_bib78","article-title":"DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach","volume":"42","author":"Pires","year":"2014","journal-title":"Web Server Issue Published Online"},{"key":"10.1016\/j.compbiomed.2025.110001_bib79","author":"Pires"},{"issue":"48","key":"10.1016\/j.compbiomed.2025.110001_bib80","doi-asserted-by":"crossref","first-page":"46265","DOI":"10.1074\/jbc.M207135200","article-title":"Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor","volume":"277","author":"Stamos","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110001_bib81","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1039\/C7SC04761D","article-title":"L718Q mutant EGFR escapes covalent inhibition by stabilizing a non-reactive conformation of the lung cancer drug osimertinib","volume":"9","author":"Callegari","year":"2018","journal-title":"Chem. Sci."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110001_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43042-021-00181-w","article-title":"Computer-aided design of some quinazoline analogues as epidermal growth factor receptor inhibitors","volume":"22","author":"Ibrahim","year":"2021","journal-title":"Egyptian Journal of Medical Human Genetics"},{"key":"10.1016\/j.compbiomed.2025.110001_bib83","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.lungcan.2017.04.003","article-title":"Emergence of novel and dominant acquired EGFR solvent-front mutations at Gly796 (G796S\/R) together with C797S\/G and L792F\/H mutations in one EGFR (L858R\/T790M) NSCLC patient who progressed on osimertinib","volume":"108","author":"Ou","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.compbiomed.2025.110001_bib84","article-title":"Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CLpro)","volume":"1","author":"Koulgi","year":"2020","journal-title":"J. Biomol. Struct. Dynam."},{"key":"10.1016\/j.compbiomed.2025.110001_bib85","doi-asserted-by":"crossref","first-page":"5796","DOI":"10.1016\/j.csbj.2023.11.009","article-title":"Prediction of protein-ligand binding affinity with deep learning","volume":"21","author":"Wang","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110001_bib86","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1021\/acs.jcim.9b00361","article-title":"Exploring gatekeeper mutations in EGFR through computer simulations","volume":"59","author":"Kannan","year":"2019","journal-title":"J. Chem. Inf. Model."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110001_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223464","article-title":"Molecular dynamic simulations to investigate the structural impact of known drug resistance mutations on HIV-1C Integrase-Dolutegravir binding","volume":"15","author":"Chitongo","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiomed.2025.110001_bib88","author":"Kujtan"},{"key":"10.1016\/j.compbiomed.2025.110001_bib89","doi-asserted-by":"crossref","unstructured":"Vasan, N., Baselga, J., & Hyman, D. M. (n.d.). A view on drug resistance in cancer HHS Public Access. https:\/\/doi.org\/10.1038\/s41586-019-1730-1.","DOI":"10.1038\/s41586-019-1730-1"},{"issue":"13","key":"10.1016\/j.compbiomed.2025.110001_bib90","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1158\/0008-5472.CAN-22-3059","article-title":"Metabolic reprogramming driven by IGF2BP3 promotes acquired resistance to EGFR inhibitors in non\u2013small cell lung cancer","volume":"83","author":"Lin","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.compbiomed.2025.110001_bib91","author":"Chhouri"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110001_bib92","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-023-01082-8","article-title":"Toward the next generation EGFR inhibitors: an overview of osimertinib resistance mediated by EGFR mutations in non-small cell lung cancer","volume":"21","author":"Li","year":"2023","journal-title":"Cell Commun. Signal. : CCS"},{"key":"10.1016\/j.compbiomed.2025.110001_bib93","article-title":"Case Report: a patient with the rare third-generation TKI-resistant mutation EGFR L718Q who responded to afatinib plus cetuximab combination therapy","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110001_bib94","first-page":"4005","article-title":"Acquired rare recurrent EGFR mutations as mechanisms of resistance to Osimertinib in lung cancer and in silico structural modelling","volume":"10","author":"Lin","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"20","key":"10.1016\/j.compbiomed.2025.110001_bib95","doi-asserted-by":"crossref","first-page":"8552","DOI":"10.1021\/acs.jmedchem.7b01075","article-title":"In silico identification of a novel hinge-binding scaffold for kinase inhibitor discovery","volume":"60","author":"Wang","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2025.110001_bib96","volume":"14","author":"Fabbro","year":"2015","journal-title":"INTERNATIONAL UNION OF BASIC AND CLINICAL PHARMACOLOGY REVIEW Ten things you should know about protein kinases: IUPHAR Review"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110001_bib97","article-title":"Erlotinib in the treatment of non-small cell lung cancer: current status and future developments","volume":"30","author":"Gridelli","year":"2010","journal-title":"Anticancer Res."},{"issue":"42","key":"10.1016\/j.compbiomed.2025.110001_bib98","doi-asserted-by":"crossref","first-page":"37654","DOI":"10.1021\/acsomega.2c04522","article-title":"Computational and structural analysis to assess the pathogenicity of bardet-biedl syndrome related missense variants identified in bardet-biedl syndrome 10 gene (BBS10)","volume":"7","author":"Gupta","year":"2022","journal-title":"ACS Omega"},{"issue":"18","key":"10.1016\/j.compbiomed.2025.110001_bib99","doi-asserted-by":"crossref","first-page":"14085","DOI":"10.1021\/acs.chemrev.1c00757","article-title":"Protein design: from the aspect of water solubility and stability","volume":"122","author":"Qing","year":"2022","journal-title":"Chem. Rev."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001048252500352X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001048252500352X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T17:20:25Z","timestamp":1769275225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001048252500352X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":99,"alternative-id":["S001048252500352X"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110001","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The coevolutionary landscape of drug resistance in epidermal growth factor receptor: A cancer perspective","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110001"}}